Clinicopathological correlation analysis showed that, except for gender (Fig. 2H), the expression level of DNAJC3 was significantly correlated with age (Fig. 2C), methylguanine-DNA methyltransferase promoter methylation status (Fig. 2D), isocitrate dehydrogenase (IDH) mutation status (Fig. 2E), WHO grade (Fig. 2F), and transcriptome subtype (Fig. 2G) of glioma patients. Here, IDH1 is linked to central nervous system cancer.